Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.001 Å; R factor = 0.030; wR factor = 0.089; data-to-parameter ratio = 32.5.
Related literature
For the pharmacological properties of quinazolinone derivatives, see: Prakash Naik et al. Sikorska et al. (1998) . For the stability of the temperature controller used in the data collection, see: Cosier & Glazer (1986) . For hydrogen-bond motifs, see: Bernstein et al. (1995) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (Bembenek et al., 2010) and antibacterial drugs (Miller et al., 2010) . New complexes have been prepared from 2-amino-4-chlorobenzoic acid by Sikorska et al., (1998) .
The title compound ( Fig. 1 ) is almost planar with maximum deviation of 0.097 (1) Å at atom O1. An intramolecular N1-H1N1···O1 hydrogen bond generates S(6) ring motif (Bernstein et al., 1995) . In the crystal, the molecules are linked into centrosymmetric dimers by O2-H1O2···O1 hydrogen bonds and these dimers are stacked down b axis (Fig. 2, Table 1 ).
The attempt to prepare the Schiff base ligand by stirring 2-amino-4-chlorobenzoic acid (1 mol) and salicyldehyde (1 mol) together at 70 °C for 3 h in 10 ml of ethanol was unsuccessful. The resulting orange solution was filtered and orange needles were formed after a few days of slow evaporation of the solvent at room temperature. Unfortunately, the crystals were that of the starting material (2-amino-4-chlorobenzoic acid) with melting point 119 °C.
Refinement
The O-and N-bound hydrogen atoms were located from difference Fourier map and refined freely. The rest of hydrogen atoms were positioned geometrically [C-H = 0.93 Å] and refined using a riding model [U iso (H) = 1.2U eq (C)].
Figures Fig. 1 . The molecular structure of title compound with 50% probability ellipsoids for non-H atoms.
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Special details
Experimental. The crystal was placed in the cold stream of an Oxford Cryosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986 ) operating at 100.0 (1) K. 
